Matthew Boland Yurgelun, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms, Hereditary Nonpolyposis | 33 | 2023 | 382 | 12.130 |
Why?
|
Germ-Line Mutation | 27 | 2023 | 1786 | 3.890 |
Why?
|
Colorectal Neoplasms | 31 | 2023 | 6726 | 3.240 |
Why?
|
DNA Mismatch Repair | 14 | 2023 | 423 | 2.380 |
Why?
|
Genetic Testing | 27 | 2023 | 3441 | 2.350 |
Why?
|
Pancreatic Neoplasms | 19 | 2023 | 5213 | 1.970 |
Why?
|
Microsatellite Instability | 11 | 2023 | 673 | 1.610 |
Why?
|
DNA Glycosylases | 6 | 2020 | 127 | 1.570 |
Why?
|
Neoplastic Syndromes, Hereditary | 7 | 2023 | 240 | 1.430 |
Why?
|
Genetic Predisposition to Disease | 33 | 2023 | 17384 | 1.410 |
Why?
|
Intestinal Polyposis | 3 | 2020 | 44 | 1.370 |
Why?
|
Genetic Counseling | 8 | 2022 | 601 | 1.210 |
Why?
|
Adenomatous Polyposis Coli | 4 | 2021 | 224 | 1.190 |
Why?
|
Adenoma | 6 | 2023 | 2167 | 1.060 |
Why?
|
Adenocarcinoma | 10 | 2022 | 6318 | 0.950 |
Why?
|
Endometrial Neoplasms | 4 | 2023 | 1351 | 0.850 |
Why?
|
Jews | 2 | 2020 | 385 | 0.800 |
Why?
|
Appendiceal Neoplasms | 1 | 2023 | 145 | 0.800 |
Why?
|
Germ Cells | 8 | 2022 | 627 | 0.760 |
Why?
|
Carcinoma, Pancreatic Ductal | 7 | 2023 | 1607 | 0.740 |
Why?
|
MutS Homolog 2 Protein | 5 | 2023 | 199 | 0.730 |
Why?
|
Genes, APC | 1 | 2020 | 159 | 0.720 |
Why?
|
BRCA2 Protein | 3 | 2022 | 788 | 0.660 |
Why?
|
Stomach Diseases | 1 | 2020 | 133 | 0.660 |
Why?
|
Watchful Waiting | 2 | 2020 | 489 | 0.640 |
Why?
|
Stomach Neoplasms | 4 | 2021 | 1318 | 0.630 |
Why?
|
Colectomy | 3 | 2020 | 681 | 0.630 |
Why?
|
Colonic Neoplasms | 2 | 2021 | 2530 | 0.600 |
Why?
|
DNA Mutational Analysis | 6 | 2018 | 4182 | 0.600 |
Why?
|
BRCA1 Protein | 3 | 2022 | 1143 | 0.580 |
Why?
|
Urologic Neoplasms | 1 | 2019 | 307 | 0.540 |
Why?
|
Heredity | 5 | 2021 | 153 | 0.520 |
Why?
|
High-Throughput Nucleotide Sequencing | 10 | 2021 | 3571 | 0.510 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2015 | 114 | 0.490 |
Why?
|
Neoplasms | 10 | 2022 | 21507 | 0.480 |
Why?
|
Ovarian Neoplasms | 4 | 2023 | 4815 | 0.450 |
Why?
|
Medical History Taking | 5 | 2020 | 782 | 0.440 |
Why?
|
Base Pair Mismatch | 1 | 2012 | 97 | 0.420 |
Why?
|
Humans | 88 | 2024 | 739398 | 0.410 |
Why?
|
Radiotherapy | 2 | 2020 | 1526 | 0.390 |
Why?
|
Pedigree | 6 | 2021 | 4640 | 0.380 |
Why?
|
Risk Assessment | 13 | 2022 | 23294 | 0.380 |
Why?
|
Polyps | 1 | 2012 | 189 | 0.370 |
Why?
|
Genetics, Population | 1 | 2015 | 931 | 0.370 |
Why?
|
ras Proteins | 2 | 2015 | 1062 | 0.370 |
Why?
|
Penetrance | 4 | 2022 | 381 | 0.350 |
Why?
|
Gene Frequency | 4 | 2020 | 3585 | 0.350 |
Why?
|
Colonoscopy | 3 | 2020 | 1363 | 0.340 |
Why?
|
Phenotype | 9 | 2021 | 16301 | 0.330 |
Why?
|
Early Detection of Cancer | 6 | 2022 | 3051 | 0.320 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 2948 | 0.320 |
Why?
|
DNA Repair | 3 | 2018 | 2030 | 0.310 |
Why?
|
Neoplasm Proteins | 3 | 2018 | 3694 | 0.300 |
Why?
|
Microsatellite Repeats | 3 | 2021 | 797 | 0.290 |
Why?
|
Adenomatous Polyposis Coli Protein | 3 | 2018 | 188 | 0.280 |
Why?
|
Mutation | 10 | 2023 | 29658 | 0.270 |
Why?
|
Female | 42 | 2023 | 378853 | 0.260 |
Why?
|
Risk Factors | 17 | 2023 | 71974 | 0.260 |
Why?
|
Proto-Oncogene Proteins | 3 | 2023 | 4555 | 0.250 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 8 | 2023 | 11410 | 0.250 |
Why?
|
Registries | 2 | 2020 | 8039 | 0.230 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5632 | 0.230 |
Why?
|
Male | 35 | 2023 | 349022 | 0.220 |
Why?
|
Middle Aged | 31 | 2023 | 212863 | 0.210 |
Why?
|
Hypoalbuminemia | 1 | 2023 | 86 | 0.210 |
Why?
|
Americas | 1 | 2022 | 111 | 0.210 |
Why?
|
Age Factors | 5 | 2021 | 18349 | 0.200 |
Why?
|
Adult | 25 | 2022 | 213394 | 0.190 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 1 | 2020 | 96 | 0.190 |
Why?
|
Risk | 4 | 2021 | 9684 | 0.180 |
Why?
|
Neutropenia | 2 | 2023 | 888 | 0.180 |
Why?
|
Predictive Value of Tests | 7 | 2020 | 15036 | 0.180 |
Why?
|
Smad4 Protein | 1 | 2020 | 162 | 0.180 |
Why?
|
Anus Neoplasms | 1 | 2024 | 329 | 0.180 |
Why?
|
Precancerous Conditions | 2 | 2017 | 966 | 0.180 |
Why?
|
Heterozygote | 3 | 2022 | 2798 | 0.170 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 48 | 0.170 |
Why?
|
Intestinal Neoplasms | 1 | 2021 | 319 | 0.170 |
Why?
|
Young Adult | 10 | 2021 | 56255 | 0.160 |
Why?
|
Models, Genetic | 3 | 2021 | 3493 | 0.160 |
Why?
|
Chemoprevention | 2 | 2018 | 323 | 0.150 |
Why?
|
Genes, BRCA2 | 2 | 2021 | 615 | 0.150 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2023 | 981 | 0.150 |
Why?
|
Cross-Sectional Studies | 5 | 2021 | 24714 | 0.150 |
Why?
|
Genome-Wide Association Study | 2 | 2017 | 12178 | 0.150 |
Why?
|
Aged | 22 | 2023 | 162698 | 0.150 |
Why?
|
Breast Neoplasms | 4 | 2023 | 20676 | 0.150 |
Why?
|
Esophagogastric Junction | 1 | 2019 | 312 | 0.150 |
Why?
|
Genes, BRCA1 | 2 | 2021 | 779 | 0.150 |
Why?
|
Gastric Mucosa | 1 | 2020 | 596 | 0.140 |
Why?
|
Genes, p16 | 1 | 2017 | 157 | 0.140 |
Why?
|
Sex Factors | 2 | 2021 | 10398 | 0.140 |
Why?
|
Inheritance Patterns | 1 | 2018 | 339 | 0.130 |
Why?
|
Neuroendocrine Tumors | 1 | 2021 | 593 | 0.130 |
Why?
|
Intestine, Small | 1 | 2021 | 1242 | 0.130 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13635 | 0.130 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2023 | 1674 | 0.130 |
Why?
|
New Zealand | 1 | 2015 | 355 | 0.120 |
Why?
|
Cohort Studies | 6 | 2020 | 40389 | 0.120 |
Why?
|
Cholecalciferol | 1 | 2019 | 534 | 0.120 |
Why?
|
Anilides | 1 | 2017 | 405 | 0.120 |
Why?
|
Cultural Characteristics | 1 | 2015 | 261 | 0.120 |
Why?
|
Body Composition | 1 | 2023 | 2397 | 0.120 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2018 | 588 | 0.120 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2019 | 3453 | 0.110 |
Why?
|
Genetic Variation | 2 | 2019 | 6539 | 0.110 |
Why?
|
Immunohistochemistry | 3 | 2017 | 11347 | 0.110 |
Why?
|
Endoscopy | 1 | 2022 | 1762 | 0.110 |
Why?
|
Gallbladder Neoplasms | 1 | 2014 | 182 | 0.110 |
Why?
|
Disease-Free Survival | 3 | 2018 | 6871 | 0.110 |
Why?
|
Syndrome | 1 | 2019 | 3241 | 0.110 |
Why?
|
Biliary Tract Neoplasms | 1 | 2014 | 177 | 0.110 |
Why?
|
Counseling | 2 | 2022 | 1526 | 0.110 |
Why?
|
Genetic Association Studies | 2 | 2020 | 2694 | 0.110 |
Why?
|
Papillomavirus Infections | 1 | 2024 | 1585 | 0.100 |
Why?
|
Australia | 1 | 2015 | 1162 | 0.100 |
Why?
|
Prognosis | 4 | 2022 | 28901 | 0.100 |
Why?
|
Organoplatinum Compounds | 3 | 2019 | 409 | 0.100 |
Why?
|
Double-Blind Method | 3 | 2020 | 11985 | 0.100 |
Why?
|
Cholangiocarcinoma | 1 | 2017 | 506 | 0.100 |
Why?
|
Bile Duct Neoplasms | 1 | 2017 | 564 | 0.100 |
Why?
|
Fluorouracil | 3 | 2022 | 1609 | 0.100 |
Why?
|
Oncogenes | 1 | 2016 | 1264 | 0.090 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9387 | 0.090 |
Why?
|
Vitamins | 1 | 2019 | 1602 | 0.090 |
Why?
|
Canada | 1 | 2015 | 2021 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2019 | 1575 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 2020 | 3036 | 0.080 |
Why?
|
Age of Onset | 1 | 2015 | 3263 | 0.080 |
Why?
|
Aspirin | 1 | 2020 | 3268 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2024 | 4014 | 0.080 |
Why?
|
Aged, 80 and over | 8 | 2021 | 57650 | 0.080 |
Why?
|
Carcinoma | 1 | 2019 | 2361 | 0.080 |
Why?
|
Odds Ratio | 1 | 2020 | 9846 | 0.080 |
Why?
|
Models, Statistical | 1 | 2022 | 5113 | 0.080 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3497 | 0.070 |
Why?
|
Disease Management | 1 | 2018 | 2448 | 0.070 |
Why?
|
Patient Selection | 1 | 2019 | 4211 | 0.070 |
Why?
|
Brain Neoplasms | 2 | 2019 | 8791 | 0.070 |
Why?
|
Leucovorin | 2 | 2019 | 618 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2727 | 0.070 |
Why?
|
Genomics | 2 | 2023 | 5652 | 0.070 |
Why?
|
Hysterectomy | 1 | 2012 | 926 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2017 | 2845 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2019 | 3279 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2018 | 2185 | 0.070 |
Why?
|
Prevalence | 2 | 2022 | 15153 | 0.070 |
Why?
|
Follow-Up Studies | 4 | 2020 | 38942 | 0.070 |
Why?
|
Paclitaxel | 2 | 2023 | 1701 | 0.070 |
Why?
|
Genes, Neoplasm | 2 | 2018 | 375 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5502 | 0.060 |
Why?
|
Pyridines | 1 | 2017 | 2810 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2018 | 545 | 0.060 |
Why?
|
Melanoma | 1 | 2023 | 5446 | 0.060 |
Why?
|
Adolescent | 5 | 2021 | 85405 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2019 | 19811 | 0.060 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2005 | 115 | 0.060 |
Why?
|
Mass Screening | 1 | 2019 | 5265 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 2015 | 0.060 |
Why?
|
Chemokines, CXC | 1 | 2005 | 422 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2018 | 4216 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2017 | 9622 | 0.050 |
Why?
|
Immunotherapy | 1 | 2018 | 4391 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 9812 | 0.050 |
Why?
|
Regression Analysis | 1 | 2012 | 6452 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5830 | 0.050 |
Why?
|
Cachexia | 1 | 2023 | 203 | 0.050 |
Why?
|
Computer Simulation | 1 | 2015 | 6237 | 0.050 |
Why?
|
Osteoclasts | 1 | 2005 | 731 | 0.050 |
Why?
|
Pyrimidinones | 1 | 2023 | 371 | 0.050 |
Why?
|
Albumins | 1 | 2023 | 563 | 0.050 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2023 | 643 | 0.050 |
Why?
|
Muscular Atrophy | 1 | 2023 | 346 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2015 | 3138 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 648 | 0.040 |
Why?
|
Chemokine CXCL12 | 2 | 2017 | 462 | 0.040 |
Why?
|
Genotype | 1 | 2013 | 12951 | 0.040 |
Why?
|
Lymphatic Metastasis | 2 | 2019 | 2897 | 0.040 |
Why?
|
Edema | 1 | 2023 | 791 | 0.040 |
Why?
|
Camptothecin | 1 | 2022 | 570 | 0.040 |
Why?
|
Pyridones | 1 | 2023 | 707 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2015 | 5128 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3508 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2023 | 603 | 0.040 |
Why?
|
Hyperbilirubinemia | 1 | 2017 | 73 | 0.040 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2017 | 141 | 0.040 |
Why?
|
Epistaxis | 1 | 2017 | 112 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1820 | 0.030 |
Why?
|
Intestinal Fistula | 1 | 2017 | 140 | 0.030 |
Why?
|
Angiopoietin-2 | 1 | 2017 | 167 | 0.030 |
Why?
|
Endosonography | 1 | 2019 | 610 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2018 | 551 | 0.030 |
Why?
|
Prospective Studies | 4 | 2024 | 53037 | 0.030 |
Why?
|
Intestinal Perforation | 1 | 2017 | 252 | 0.030 |
Why?
|
Animals | 4 | 2023 | 168368 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 62693 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2022 | 2208 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2455 | 0.030 |
Why?
|
Intestines | 1 | 2023 | 1919 | 0.030 |
Why?
|
Survival Rate | 2 | 2019 | 12761 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2023 | 6610 | 0.030 |
Why?
|
California | 1 | 2017 | 1400 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2017 | 578 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2005 | 2521 | 0.030 |
Why?
|
Patient Participation | 1 | 2021 | 1441 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2018 | 8400 | 0.030 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 804 | 0.030 |
Why?
|
Infant | 1 | 2013 | 34923 | 0.030 |
Why?
|
Stem Cells | 1 | 2005 | 3566 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2023 | 3280 | 0.020 |
Why?
|
Medical Oncology | 1 | 2023 | 2217 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1522 | 0.020 |
Why?
|
Immune System | 1 | 2016 | 801 | 0.020 |
Why?
|
Internal Medicine | 1 | 2017 | 996 | 0.020 |
Why?
|
Physician's Role | 1 | 2017 | 943 | 0.020 |
Why?
|
Attitude to Health | 1 | 2019 | 2047 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 1994 | 0.020 |
Why?
|
Deoxycytidine | 1 | 2014 | 825 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7275 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1706 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2017 | 1023 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2018 | 2133 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3526 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4920 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2018 | 2936 | 0.020 |
Why?
|
United States | 1 | 2015 | 69573 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2017 | 3194 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2019 | 3945 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2141 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10945 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4791 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4832 | 0.020 |
Why?
|
Mice | 2 | 2023 | 81002 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3504 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7726 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2023 | 11460 | 0.020 |
Why?
|
Vitamin D | 1 | 2019 | 3197 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12237 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 12804 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2023 | 21863 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2018 | 2986 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2019 | 10961 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12328 | 0.020 |
Why?
|
Telemedicine | 1 | 2021 | 2844 | 0.020 |
Why?
|
Mitochondria | 1 | 2017 | 3522 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3614 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2024 | 76631 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6516 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7274 | 0.010 |
Why?
|
DNA Methylation | 1 | 2017 | 4269 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10455 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13402 | 0.010 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2005 | 675 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9609 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 40802 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4743 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9259 | 0.010 |
Why?
|
Hypertension | 1 | 2017 | 8431 | 0.010 |
Why?
|
Monocytes | 1 | 2005 | 2583 | 0.010 |
Why?
|
Child | 1 | 2020 | 77033 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 35326 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2005 | 3364 | 0.010 |
Why?
|